Evidence map›Paper›PMID 41646375›Full record

ArticleResearch square2026

Fentanyl decreases blood oxygen more than furanylfentanyl despite similar effects on breathing.

Catherine Demery, Sierra C Moore, Kelsey E Kochan, Mengchu Li, Thomas D Prince, Benjamin M Clements, Zhongqi Chen, Jessica R Whitaker-Fornek, Erica S Levitt, Jessica P Anand and 1 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Catherine DemeryEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.
Sierra C MooreEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.
Kelsey E KochanEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.
Mengchu LiEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.
Thomas D PrinceEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.
Benjamin M ClementsEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.
Zhongqi ChenDepartment of Medicinal Chemistry, University of Michigan College of Pharmacy, 428 Church St., Ann Arbor, MI, 48109, USA.
Jessica R Whitaker-FornekEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.
Erica S LevittEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.
Jessica P AnandEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.
John R TraynorEdward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.

Funding

Allosteric Modulation of the Mu-Opioid ReceptorR37DA039997 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 2015 to 2024
$6.4M
NIDA Training Program in Neuroscience-Administrative SupplementT32DA007281 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Shelly Beth Flagel · 1995 to 2026
$5.7M
Michigan Chemistry-Biology Interface Training ProgramT32GM132046 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Emily E Scott, Wenjing Wang · 2019 to 2026
$4.1M
Brainstem mechanisms of opioid-induced respiratory depressionR01HL174547 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Erica Sawyer Levitt · 2024 to 2026
$1.6M
Postdoctoral Training in the Biology of Drug AbuseT32DA060142 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI John R. Traynor · 2024 to 2026
$1.5M
Novel antagonists as fentanyl overdose rescue therapiesUG3DA056884 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 2022 to 2023
$1.5M
Serotonin mechanisms in fentanyl-induced respiratory depressionR01DA061320 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Erica Sawyer Levitt · 2024 to 2026
$1.4M
CTSA Postdoctoral T32 at the University of MichiganT32TR004764 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI VICKI L ELLINGROD, Steven Edward Harte · 2024 to 2026
$1.4M
DNA methylation in normal versus malignant melanocytesR21AR051723 · NIAMS · YALE UNIVERSITY · PI WEISSMAN, SHERMAN MORTON · 2004 to 2005
$164k
Examining Novel Fentalogs: Pharmacological Characteristics and ReversibilityR03DA048129 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANAND, JESSICA PRIYA · 2019 to 2020
$156k
NCATS NIH HHS T32 TR004764NHLBI NIH HHS R01 HL174547NIAMS NIH HHS R21 AR051723NIDA NIH HHS R01 DA061320NIDA NIH HHS R03 DA048129NIDA NIH HHS R37 DA039997NIDA NIH HHS T32 DA007281NIDA NIH HHS T32 DA060142NIDA NIH HHS UG3 DA056884NIGMS NIH HHS T32 GM132046
6 · The paper itself

Abstract

Rationale: Fatal opioid overdoses involving synthetic opioids have increased >10-fold over the past 8 years. Fentanyl, a potent synthetic opioid acting at the mu-opioid receptor (MOR), has largely replaced heroin as the predominant illicit opioid available. Various analogs have been synthesized from the fentanyl scaffold, including 2-furanylfentanyl, one of the most trafficked analogs from 2019 to 2024. Despite its prevalence, the Objectives: To characterize furanylfentanyl relative to fentanyl Methods: The affinity and potency of fentanyl and furanylfentanyl were determined in CHO cells overexpressing MOR. Male and female mice were administered ( Results: Furanylfentanyl behaves as a partial agonist Conclusions: These results highlight the complexity of fentanyl-induced respiratory depression and indicate that recreational use of 2-furanylfentanyl in humans may pose a greater risk of overdose than morphine but lesser than fentanyl.

Indexed as

apneasfentanylFuranylfentanylmousemu-opioid receptoropioidoverdoseoxygen saturationplethysmographyrespiratory depression

Identifiers

PMID41646375
PMCPMC12869654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.